Portable liquid helium-free MRI-guided proton therapy system
A portable MRI-guided proton therapy system using high-temperature superconductors addresses the lack of real-time imaging in proton therapy, providing accurate tumor targeting and reducing healthy tissue risk through compact, cost-effective MRI integration.
Patent Information
- Application Number
- PCT/US2025/011834
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-01-16
- Filing Date
- 2025-01-16
- Publication Date
- 2025-07-24
AI Technical Summary
Current proton therapy systems lack accurate real-time imaging guidance, particularly for distinguishing tumors from healthy tissues, due to limitations in existing imaging technologies such as 2D orthogonal X-ray imaging, with MRI guidance not yet available for clinical use.
A portable MRI-guided proton therapy system utilizing high-temperature superconductors like magnesium diboride (MgB2) for the MRI assembly, eliminating the need for liquid helium cooling, allowing for compact, cost-effective, and real-time MRI imaging during proton therapy.
Enables accurate real-time imaging and treatment monitoring, enhancing tumor targeting and reducing risk to healthy tissues by leveraging MRI's soft tissue differentiation and functional imaging capabilities.